CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $58,826
- in 14 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$58,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +500 | $0.09 | $44 | 401,762 |
| 2025-03-05 | Equels Thomas K CEO & President | Purchase | +50,000 | $0.13 | $7K | 1,858,029 |
| 2025-03-04 | Equels Thomas K CEO & President | Purchase | +44,000 | $0.12 | $5K | 1,808,029 |
| 2025-03-04 | Equels Thomas K CEO & President | Purchase | +83,334 | $0.12 | $10K | 1,764,029 |
| 2024-12-18 | Equels Thomas K CEO & President | Purchase | +22,727 | $0.21 | $5K | 1,680,695 |
| 2024-12-02 | APPELROUTH STEWART Director | Purchase | +1 | $0.21 | $0 | 344,398 |
| 2024-12-02 | APPELROUTH STEWART Director | Purchase | +11,111 | $0.21 | $2K | 355,509 |
| 2024-11-21 | Equels Thomas K CEO & President | Purchase | +20,000 | $0.21 | $4K | 1,657,968 |
| 2024-11-20 | Equels Thomas K CEO & President | Purchase | +85,000 | $0.20 | $17K | 1,637,968 |
| 2024-11-20 | APPELROUTH STEWART Director | Purchase | +81,953 | $0.19 | $16K | 321,752 |
| 2024-11-20 | Equels Thomas K CEO & President | Purchase | +60,110 | $0.18 | $11K | 1,552,968 |
| 2024-09-16 | Equels Thomas K CEO & President | Purchase | +5,000 | $0.30 | $2K | 1,493,042 |
| 2024-09-13 | Equels Thomas K CEO & President | Purchase | +20,000 | $0.31 | $6K | 1,488,042 |
| 2024-05-06 | Equels Thomas K CEO & President | Purchase | +61,729 | $0.41 | $25K | 778,184 |
| 2024-05-06 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +30,865 | $0.41 | $13K | 212,583 |
| 2024-03-21 | BRYAN NANCY Director | Purchase | +38,462 | $0.39 | $15K | 38,462 |
| 2024-03-15 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +37,879 | $0.33 | $13K | 181,718 |
| 2024-03-15 | Equels Thomas K CEO & President | Purchase | +75,758 | $0.33 | $25K | 716,455 |
| 2024-03-15 | APPELROUTH STEWART Director | Purchase | +90,910 | $0.33 | $30K | 239,765 |
| 2023-11-27 | Equels Thomas K CEO & President | Purchase | +33,861 | $0.44 | $15K | 640,697 |
Page 2 of 9 · 169 trades